Toggle sidebar
定价
登录
Scholar Rock's drug for a rare neuromuscular disease
搜索文档
US FDA declines to approve Scholar Rock's muscle weakness drug
Reuters
·
2025-09-23 19:12
监管决定 - 美国食品药品监督管理局拒绝批准Scholar Rock公司针对一种罕见神经肌肉疾病的药物[1] - 监管机构拒绝批准的理由是第三方生产设施存在问题[1]
Scholar Rock(US:SRRK)
Pharmaceuticals
Scholar Rock's drug for a rare neuromuscular disease
Pharmaceuticals
Scholar Rock's drug for a rare neuromuscular disease
